Conference abstract · 6 Dec 2019
EditorialPublished 2015
The Microbiome and Diet: Friend or Foe in the Future Treatment of Inflammatory Bowel Disease?
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
It is well established that uncontrolled activation of effector immune cells in response to the gut microbiota triggers chronic inflammatory bowel disease (IBD) symptoms in genetically susceptible hosts. The exact cause(s) for IBD remains unknown. Previous studies have examined, in detail, how the gut microbiome, genetic susceptibility, and environmental stress may activate the immune responses associated with IBD. Recent studies show that a high fat diet alters the gut microbiota structure and function and facilitates the initiation and progression of immune responses responsible for IBD outcome. Some recent studies also clearly suggest that changes in pathobionts lead to an altered immune response and disease progression. This editorial focuses on some information provided in these studies and addresses how high fat diet induced alteration in the gut microbiota affect IBD progression. We provide some suggestions on how our current knowledge might be used to develop new dietary microbial and immune based modulation strategies for risk assessment and treatment of IBD.
Subjects
MicrobiologyInfectious DiseasesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Conference abstract · 6 Dec 2019
Novel Microbiome-based therapy for the treatment of Inflammatory Bowel Disease
Commentary · 2012
Microbial Links to Inflammatory Bowel Disease Development: Potential Interventional Strategies in Treatment
Article · 29 Apr 2024
Exploring the Gut Microbiome Signature in Inflammatory Bowel Disease Patients: Metagenomic Analysis and Functional Profiling
Article · 10 Oct 2020
Anti-inflammatory effect of Linum usitassimum (Flaxseed/linseed) fixed oil on inflammatory bowel disease in mice
More from this journal
The newest in Clinical Microbiology: Open Access.
Article · 18 Dec 2025
Molecular and Proteomic Strategies for Reliable Microbial Identification
Article · 18 Dec 2025
Culture-Based and Molecular Assessment of Microbial Diversity
Article · 18 Dec 2025
Antimicrobial Resistance Detection and Microbial Identification
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalClinical Microbiology: Open Access
- SubjectMicrobiology
- SubjectInfectious Diseases
- BylineArticles whose byline prints “Udai P Singh”
